Carboplatin for injection

DRUG2 trials

Sponsors

Shanghai Hengrui Pharmaceutical Co., Ltd., Jiangsu HengRui Medicine Co., Ltd.

Conditions

Advanced Solid TumorsEarly-stage or Locally Advanced HER2-positive Breast Cancer

Phase 1

A Phase IB/II Clinical Study of SHR-9839 for Injection Combined With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors

RecruitingNCT06474455

Shanghai Hengrui Pharmaceutical Co., Ltd.Advanced Solid Tumors

Start: 2024-07-02End: 2029-12-01Target: 156Updated: 2026-05-11

Phase 3

A Trial of SHR-A1811 Compared to Other Antitumor Therapies as Neoadjuvant Treatments in Early-stage or Locally Advanced HER2-positive Breast Cancer

RecruitingNCT07196774

Jiangsu HengRui Medicine Co., Ltd.Early-stage or Locally Advanced HER2-positive Breast Cancer

Start: 2025-10-23End: 2028-12-01Target: 740Updated: 2026-01-30